Fat Mass and Resistin: Predictive Factors For Anti-TNF Therapy Response In Ankylosing Spondylitis Patients

被引：0
|
作者：
Saad, Carla G. S. [1 ]
Abreu, Andressa Silva [1 ]
Medeiros Ribeiro, Ana Cristina [1 ]
Moraes, Julio C. B. [1 ]
Perandini, Luiz A. [1 ]
Dassouki, Thalita [1 ]
Pereira, Rosa M. R. [1 ]
Bonfa, Eloisa [1 ]
Pinto, Ana Lucia S. [1 ]
机构：
[1] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2474
引用
收藏
页码：S1058 / S1058
页数：1
相关论文
共 50 条
  • [21] A cost efficacy analysis on anti-TNF therapy in ankylosing spondylitis
    Singh, G
    Tandon, N
    Bala, M
    VALUE IN HEALTH, 2004, 7 (06) : 663 - 664
  • [22] Anti-TNF therapy in the treatment of ankylosing spondylitis:: the Finnish experience
    Konttinen, Liisa
    Tuompo, Riitta
    Uusitalo, Tea
    Luosujarvi, Riitta
    Laiho, Kari
    Lahteenmaki, Jukka
    Puurtinen-Vilkki, Maija
    Lanteri, Ritva
    Kortelainen, Saara
    Karilainen, Helena
    Varjolahti-Lehtinen, Tuire
    Nordstrom, Dan
    CLINICAL RHEUMATOLOGY, 2007, 26 (10) : 1693 - 1700
  • [23] METABOLIC SYNDROME IN ANKYLOSING SPONDYLITIS AND THE EFFECT OF ANTI-TNF THERAPY
    Atzeni, F.
    Gianturco, L.
    Masala, I. F.
    Bongiovanni, S.
    Boccassini, L.
    Sarzi-Puttini, P.
    Turiel, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1294 - 1294
  • [24] A cost efficacy analysis on anti-TNF therapy in ankylosing spondylitis
    Singh, G
    Tandon, N
    Bala, M
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 395 - 395
  • [25] SECONDARY AMYLOIDOSIS IN ANKYLOSING SPONDYLITIS AND THE ROLE OF ANTI-TNF THERAPY
    Donmez, S.
    Pamuk, O. N.
    Pamuk, G. E.
    Aydogdu, E.
    Inman, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (04) : 613 - 613
  • [26] Anti-TNF Therapy Slows Radiographic Progression of Ankylosing Spondylitis
    Haroon, Nigil
    Inman, Robert D.
    Learch, Thomas J.
    Weisman, Michael H.
    Ward, Michael M.
    Reveille, John D.
    Gensler, Lianne S.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S339 - S340
  • [27] Circulating MiR-145 As a Marker of Therapeutic Response to Anti-TNF Therapy in Patients with Ankylosing Spondylitis
    Prajzlerova, Klara
    Hruskova, Veronika
    Komarc, Martin
    Forejtova, Sarka
    Pavelka, Karel
    Vencovsky, Jiri
    Senolt, Ladislav
    Filkova, Maria
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [28] Circulating miR-145 as a Marker of Therapeutic Response to Anti-TNF Therapy in Patients With Ankylosing Spondylitis
    Prajzlerova, Klara
    Komarc, Martin
    Forejtova, Sarka
    Pavelka, Karel
    Vencovsky, Jiri
    Senolt, Ladislav
    Filkova, Maria
    PHYSIOLOGICAL RESEARCH, 2021, 70 (02) : 255 - 264
  • [29] Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNF alpha drugs
    Perrotta, F. M.
    Addimanda, O.
    Ramonda, R.
    D'Angelo, S.
    Lubrano, E.
    Marchesoni, A.
    Olivieri, I.
    Punzi, L.
    Salvarani, C.
    Spadaro, A.
    REUMATISMO, 2014, 66 (03) : 208 - 214
  • [30] The inadequate anti-tumour necrosis factor (anti-TNF) therapy in patients with ankylosing spondylitis
    Pinar Borman
    Figen Ayhan
    Esma Ceceli
    Rheumatology International, 2010, 30 : 1689 - 1690
12345